account* New data shows degludec superior to Lantus * Sanofi gaining, Eli Lilly losing market share * Has begun phase IIIa clinical trial of haemophilia compound COPENHAGEN, May 5 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO The world's biggest maker...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Novo Nordisk says new data shows degludec superior
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account